. Invention also relates to a pharmaceutical composition having an inhibiting effect with respect to the receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) on the basis of said compounds. ;EFFECT: technical result consists in producing novel compounds and a pharmaceutical composition on the basis of said compounds, which can be used in medicine for treating epilepsy.;16 cl, 4 tbl, 2 dwg, 22 ex"/>
公开/公告号RU2743998C2
专利类型
公开/公告日2021-03-01
原文格式PDF
申请/专利权人 EISAI R&D MANAGEMENT CO. LTD.;
申请/专利号RU20180115716
发明设计人 KUROKAWA TOSHIKI (JP);YOSHIDA YU (JP);SHIN KOGYOKU (JP);KOBAYASHI YOSHIHISA (JP);FUKUMOTO HIRONORI (JP);TAKEDA KUNITOSHI (JP);OHASHI YOSHIAKI (JP);KOTAKE MAKOTO (JP);SHIBUGUCHI TOMOYUKI (JP);WATANABE TORU (JP);KITA YOICHI (JP);HIROTA SHINSUKE (JP);FUKUYAMA TAKASHI (JP);KAMADA YASUAKI (JP);
申请日2016-11-09
分类号C07D491/147;A61K31/4375;A61K31/506;A61K31/444;A61P25;A61P25/08;
国家 RU
入库时间 2022-08-24 17:25:39